Find Academic Supervisors

Sunil SharmaView profile

Associate Clinical Professor

• Radiation Physics
• Radiation Dosimetry
• Radiation Oncology
• +7 more

Sunil Sharma, PhD is a Clinical Associate Professor in the Department of Radiation Oncology at East Carolina University's Brody School of Medicine. He is board certified by the American Board of Radiology in Therapeutic Radiological Physics and has extensive expertise in radiation therapy systems including treatment planning (ADAC Pinnacle, XIO, VARIAN Eclipse), teletherapy (Varian Clinac IX, TrueBeam, TOMOTHERAPY), Cyber Knife, Gamma Knife, and brachytherapy techniques. Dr. Sharma's research focuses on radiation physics, dosimetry, and radiation-induced heart disease. His work spans preclinical small animal irradiation research and clinical radiation therapy applications. He has developed image-guided techniques for local heart irradiation in rat models and has investigated the effects of radiation on cardiac mitochondria, oxidative stress pathways, and inflammatory responses. His recent publications (2017-2023) demonstrate continued research in stereotactic radiosurgery, fiducial tracking for lung tumors, image quality assessment in small animal irradiators, and advanced radiation delivery techniques including GRID therapy. His work shows an evolving focus from fundamental radiation physics to translational applications in cancer treatment. Dr. Sharma has held academic positions at East Carolina University since 2015 and previously at the University of Arkansas for Medical Sciences. He has collaborated extensively with researchers in radiation oncology, medical physics, and cardiovascular biology, resulting in 53 publications with approximately 725 citations. His laboratory work centers around the Small Animal Conformal Radiation Therapy Device (SACRTD), which integrates 3D-conformal radiation therapy delivery with CBCT imaging capabilities using a robotic arm system. This platform enables precise radiation delivery for preclinical research with direct clinical translation potential.

Ramazan ULUView profile

Professor

• Nephrology
• Internal Medicine
• Chronic Kidney Disease
• +5 more

Professor Ramazan ULU is a distinguished academic and clinician in the Department of Internal Medical Sciences at Adiyaman University Faculty of Medicine. With a medical degree from Erciyes University and specialized training from Inonu and Firat Universities, he has established himself as a leading researcher in nephrology and internal medicine. His academic journey includes serving as an Assistant Professor in the Department of Nephrology at Firat University before advancing to his current professorship at Adiyaman University. Professor ULU's research primarily focuses on chronic kidney disease, dialysis modalities, diabetes complications in renal patients, and oxidative stress mechanisms in kidney injury. His work bridges clinical practice and experimental research, investigating both patient outcomes and molecular pathways of renal damage. He has made significant contributions to understanding biomarkers like NGAL (neutrophil gelatinase-associated lipocalin) in hemodialysis patients and exploring natural compounds for renal protection against nephrotoxic agents. His publication record shows consistent productivity with numerous articles in both international and national journals, demonstrating expertise in clinical nephrology, renal pathophysiology, and translational research. Professor ULU frequently collaborates with multidisciplinary teams across Turkish medical institutions, contributing to advancements in renal care and internal medicine practice. Best Poster Award recipient Anadolu Böbrek Vakfı award recipient Active reviewer for Fırat Tıp Dergisi (2017) Professor ULU maintains active clinical practice alongside his academic responsibilities, with extensive experience in both public healthcare (Ministry of Health) and private medical centers. His dual expertise in clinical medicine and academic research makes him a valuable mentor for medical students and residents in internal medicine and nephrology specialties.

• Psychiatry
• Disaster Mental Health
• Trauma Psychology
• +7 more

Dr. Şeyma SEHLİKOĞLU serves as an Assistant Professor in the Department of Internal Medical Sciences at Adiyaman University Faculty of Medicine. She completed her medical education at Gaziantep University (2007-2014) followed by medical specialization in Psychiatry at Adiyaman University (2016-2021). Her research primarily focuses on disaster mental health, with significant contributions examining the psychological impacts of the February 2023 Kahramanmaraş earthquakes in Turkey. She investigates PTSD, prolonged grief disorder, suicide risk, and various psychiatric outcomes in earthquake survivors, particularly those with physical injuries or limb loss. Additional research interests include anxiety disorders, psychotic disorders, forensic psychiatry, and substance use disorders. Dr. SEHLİKOĞLU has published extensively, with 32 articles, 6 books, and 25 conference proceedings to her name. Her recent work (2023-2025) demonstrates a strong emphasis on the mental health consequences of natural disasters, with multiple studies examining specific populations including healthcare workers, postpartum women, and individuals with physical disabilities following the earthquakes. She teaches a comprehensive range of psychiatric subjects including Forensic Psychiatry, Schizophrenia Spectrum Disorders, Anxiety Disorders, Psychiatric Ethics, and Neurocognitive Disorders. Her clinical work includes serving as a Psychiatrist at the TC Ministry of Health Adiyaman University Training and Research Hospital (2021-2023) before transitioning to her current academic position. Dr. SEHLİKOĞLU is an active member of the Turkish Psychiatric Association and serves on the Education and Training Commission at Adiyaman University (2023-2024). Her current research projects focus on psychoeducation programs for substance use disorder following disasters and forensic evaluations of domestic violence perpetrators.

• Pharmacology
• Pharmaceutical Sciences
• Clinical Pharmacology
• +7 more

Dr Lisa Pont is a Professor in the Discipline of Pharmacy within the Graduate School of Health at the University of Technology Sydney (UTS), where she also serves as Deputy Head of School for Teaching and Learning. She is a registered pharmacist with extensive expertise in clinical pharmacology and medication safety, contributing significantly to research in antimicrobial resistance, pharmacoepidemiology, and quality use of medicines. Dr Pont's educational background includes: PhD in Clinical Pharmacology on Quality Use of Medicines from the University of Groningen, The Netherlands MSc in Epidemiology from the London School of Hygiene & Tropical Medicine Bachelor of Pharmacy from the University of Tasmania Bachelor of Science from the University of Newcastle Australia Her research focuses on improving medication safety and optimizing drug therapy across various healthcare settings. Dr Pont has made significant contributions to understanding antimicrobial resistance patterns, particularly in community and long-term care settings. Her work examines how community pharmacists can enhance antibiotic stewardship and how data systems can track medication utilization to improve access to therapies. She has developed and validated assessment tools for medication safety processes in nursing homes and investigates the relationship between medication safety practices and actual medication use. Dr Pont's expertise extends to pharmacoepidemiology, with particular interest in drug utilization research methods and applications across the Western Pacific Region. Dr Pont's recent publications demonstrate a strong focus on medication safety in aged care, antimicrobial resistance surveillance, and the impact of drug shortages on prescribing practices. Her work spans both clinical and policy-relevant research, often employing mixed-methods approaches including systematic reviews, cross-sectional surveys, and longitudinal data analysis. A notable trend in her research is the application of real-world data to address pressing medication safety issues in community and institutional settings, with increasing attention to geospatial analysis of resistance patterns and nanoparticle drug delivery systems. Dr Pont is actively involved in mentoring research students and has indicated availability for Masters Research or PhD student supervision. Her collaborative research network spans multiple countries and institutions, reflecting the international relevance of her work in pharmaceutical care and medication safety. She is a member of the UTS Ageing Research Collaborative (UARC) and contributes to the UTS Research Centre, demonstrating her commitment to interdisciplinary research approaches.

• Social Anxiety Disorder
• Cognitive Behavioral Therapy
• Neuroimaging
• +5 more

Professor Tomas Furmark is a prominent researcher at Uppsala University's Department of Psychology, specializing in Emotion Psychology. His work focuses extensively on social anxiety disorder, cognitive behavioral therapy, and neuroimaging techniques to understand the biological underpinnings of anxiety disorders. He maintains an active research program with numerous publications in high-impact journals. His research interests include: Social Anxiety Disorder and its neurobiological mechanisms Cognitive Behavioral Therapy (CBT) and internet-delivered treatments Neuroimaging (PET, fMRI) of anxiety disorders Serotonin and dopamine systems in anxiety Placebo effects in psychiatric treatment Memory reconsolidation in fear processing Professor Furmark's publication record demonstrates a consistent focus on understanding the neural mechanisms of social anxiety disorder through advanced imaging techniques. His recent work examines treatment mechanisms, biomarkers for treatment response, and the interplay between pharmacological and psychological interventions. He frequently collaborates with international research groups, particularly within the ENIGMA consortium for large-scale neuroimaging studies. His research has important clinical implications for understanding treatment mechanisms and developing more targeted interventions for anxiety disorders. Professor Furmark has contributed significantly to the understanding of how cognitive behavioral therapy induces neuroplastic changes and how placebo effects interact with biological treatments.

Marc RobertsonView profile

Associate Professor

• Balance Assessment
• Dynamic Walking Biomechanics
• Geriatric Exercise Prescription
• +5 more

Marc Robertson is an Associate Professor and Director of the Health Science (BHSc) Program within the Health & Movement Sciences school at Southern Connecticut State University (SCSU). He holds advanced degrees in Exercise Science and Physical Therapy, with prior experience in private practice and adjunct teaching. His current research focuses on dynamic balance mechanisms and fall prevention strategies across the lifespan. Undergraduate: Exercise Science (SCSU), Physical Therapy (UConn) Graduate: Exercise Science (SCSU), Post-Professional Doctoral Degree in Physical Therapy Research interests include balance assessment , ambulation mechanics , and geriatric exercise prescription . His work explores biomechanical changes in aging populations and develops clinical tools for evaluating dynamic walking balance. Recent publications analyze muscular strength assessment , insole technology , and age-related mobility patterns . He has presented at major symposia including the American College of Sports Medicine and Connecticut Athletic Trainers' Association conferences. Active in curriculum development, he co-designed a digital portfolio capstone assignment and enhanced medical documentation training through internal university grants. His work bridges clinical practice and academic research in exercise science.

• Nephrology
• Immunology
• Pathology
• +5 more

Alastair Hansen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Pathology. His academic work is based at Herlev Hospital (Borgmester Ib Juuls Vej 1, 2730 Herlev), where he maintains an active research profile with numerous publications in clinical medicine. Dr. Hansen's research primarily focuses on nephrology and immunology, with significant contributions to understanding glomerulonephritis, hypertensive disorders of the kidney, immunodeficiency conditions, and their relationship to various cancers. His work often bridges clinical practice with laboratory research, particularly in the areas of renal pathology and immune responses to infections. He has conducted important research on the interplay between kidney disease and other systemic conditions, including cancer and bone disorders. His publication record shows consistent output with a focus on clinical research articles in high-impact journals. The research trends demonstrate a strong emphasis on observational and case-based studies that address important clinical questions in nephrology and immunology. His work often involves large cohort studies and national registry analyses, particularly evident in his 30-year glomerulonephritis study. Dr. Hansen has collaborated extensively with researchers across multiple Danish institutions, particularly within the Capital Region of Denmark. His work shows strong connections between clinical practice at Herlev Hospital and academic research at the University of Copenhagen. He has been involved in studies examining the intersection of immunology and kidney disease, particularly during the early phases of the SARS-CoV-2 pandemic.

Benjamin Anderschou Holbech JensenView profile

Associate Professor

• Nutritional Immunology
• Compartmentalized Immunology
• Host Defence Peptides
• +7 more

Benjamin A. H. Jensen is a tenured Associate Professor in Nutritional Immunology at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. He leads the Jensen Group which focuses on barrier (dys)function and investigates how dietary components, gut microbial community structures, and compartmentalized immunology interact to orchestrate chronic inflammation. His research has been published in top-tier journals including Nature, Nature Metabolism, Cell Metabolism, and GUT. Dr. Jensen earned his PhD in Molecular Biomedicine from the University of Copenhagen in 2016, with a thesis titled "Insulin Resistance: A Fine-Tuned Interplay Between Diet, Intestinal Microbes and Immunity." Prior to this, he completed an MSc in Biochemistry with a major in Immunology (2013) and a Diploma of Engineering in Biotechnology (2012). His research interests center on nutritional immunology, particularly host defense peptides (HDPs) and their influence on host-microbe mutualism in chronic inflammatory diseases. The Jensen Group develops experimental systems tailored to model human diseases with unmet medical needs, with a specific focus on the gut-liver, gut-lung, and gut-brain axes. His work emphasizes sound and reproducible research over high-impact publications, aiming to make discoveries that benefit society. His recent publications demonstrate a strong focus on the interactions between diet, gut microbiome, and host immunity in metabolic diseases like obesity and type 2 diabetes. The research spans from basic molecular mechanisms to translational applications, with particular attention to how dietary components and host defense peptides influence disease progression and potential treatments. Emerging Excellence Investigator award, Novo Nordisk Foundation (2021) Nominated for 'Scientific Discovery of the Year' by Québec Science, Canada (2021) Featured as #BestofNatMetab2020 in Nature Metabolism (2021) Featured on the frontpage of Nature Metabolism (2020) Scientific advisor to the International Life Sciences Institute (ILSI), Europe, Probiotic Task Force (2022) Dr. Jensen serves as main supervisor for 3 postdocs (1 industrial), 1 PhD student (with 3 additional as co-supervisor), and numerous master's and bachelor's students. He has co-invented two issued patents and founded Aesculus Bio ApS. His group collaborates with academic and industrial partners across multiple countries, reflecting his international research network. He has received significant grant funding including the prestigious Novo Nordisk Foundation Excellence Emerging Investigator Grant (2021) to establish his research group. The Jensen Group operates at the intersection of nutritional science, immunology, and microbiome research, with a strong translational focus on developing novel approaches for chronic inflammatory diseases. Their work combines advanced experimental models with clinical insights to bridge the gap between basic science and therapeutic applications.

Elie NaddafView profile

Clinical Professor

• Peripheral Neuropathies
• Myopathies
• Neuromuscular Disorders
• +5 more

Dr. Elie Naddaf is a Clinical Professor in the Department of Neurology at Mayo Clinic College of Medicine, specializing in neuromuscular disorders. He serves as Scientific Committee Chair for the Myositis International Health & Research Collaborative Alliance (MIHRA) and holds leadership roles in multiple professional societies including the American Academy of Neurology and American Association of Neuromuscular and Electrodiagnostic Medicine. Dr. Naddaf earned his MD from Lebanese University School of Medicine in 2010, completed Neurology residency at University of Wisconsin Hospitals and Clinics in 2014, and Neuromuscular Medicine Fellowships at Mayo Clinic in 2016. He recently completed a Master's in Clinical and Translational Science from Mayo Graduate School in 2024. His research focuses on inclusion body myositis, peripheral neuropathies, autoimmune neuromuscular disorders, and hereditary myopathies. Analysis of his recent publications reveals significant contributions to understanding mitochondrial dysfunction in inflammatory myopathies, diagnostic criteria for neuromuscular disorders, and clinical outcomes in rare neuromuscular conditions. His work integrates clinical neurology, electrophysiology, and molecular mechanisms to advance diagnostic and therapeutic approaches. Dr. Naddaf has received numerous awards including: The Myositis Association's 2025 Heroes in Healthcare Award Mayo Clinic's 2024 Patient Experience Award American Association of Neuromuscular and Electrodiagnostic Medicine's 2023 Scientific Impact Award As an active clinician-scientist, Dr. Naddaf maintains a robust research program with extensive grant funding through Mayo Clinic's Clinical and Translational Science program. He mentors junior researchers and collaborates internationally on neuromuscular research initiatives. His clinical practice focuses on complex neuromuscular cases including amyotrophic lateral sclerosis, myasthenia gravis, and inflammatory myopathies, utilizing advanced diagnostic techniques including electromyography.

Polina MaciejczykView profile

Professor

• Atmospheric Chemistry
• Air Pollution
• Particulate Matter
• +4 more

Dr. Polina Maciejczyk is a Professor of Chemistry in the Department of Chemistry and Biochemistry at Eckerd College. She holds a Ph.D. in Chemistry from the University of Maryland and a B.S. in Chemistry from Rowan University. Her research specializes in atmospheric chemistry and air pollution health effects, with emphasis on: Source apportionment of particulate matter (PM2.5/PM10) Health impacts of metals in ambient particles Cardiovascular and inflammatory responses to pollution Statistical modeling of pollution sources Global air quality in urban environments including Beijing and Jeddah Her publications (2002-2022) demonstrate consistent focus on pollution toxicology, with recent work examining fossil fuel combustion metals. Research employs: Chemical speciation via X-ray fluorescence Mobile air monitoring systems Biometric telemetry in murine models Cellular response analysis

• Immunology
• Primary Immunodeficiency Diseases
• Allergy
• +5 more

Dr. John M. Routes is a Professor and Chief in the Division of Allergy within the Department of Pediatrics at the Medical College of Wisconsin. He is also a member of the Center for Immunology and the Mellowes Center for Genomic Sciences and Precision Medicine. With over three decades of experience in immunology research and clinical practice, Dr. Routes has established himself as a leading expert in primary immunodeficiency diseases. His educational background includes a BA with highest distinction from Indiana University-Bloomington (1973-1977) and an MD with Highest Distinction from Indiana University School of Medicine (1977-1981). He completed his internship and residency in Internal Medicine at the University of Utah Affiliated Hospitals (1981-1984), followed by dual fellowships in Allergy and Clinical Immunology (1985-1989) and Infectious Diseases (1989-1990) at the National Jewish Center for Immunology and Respiratory Medicine, University of Colorado. Dr. Routes' research program focuses on primary immunodeficiency diseases, particularly severe combined immunodeficiency (SCID) and common variable immunodeficiency (CVID). His work spans from fundamental molecular mechanisms (including T cell signaling and X chromosome inactivation) to clinical applications (such as newborn screening programs and management of pulmonary complications). He has been instrumental in implementing Wisconsin's statewide newborn screening program for SCID, which has significantly improved early detection and intervention for this life-threatening condition. His recent publications (2022-2024) demonstrate continued productivity and engagement with current challenges in the field, with research on X-chromosome inactivation in T cells, COVID-19 vaccination in immunodeficient patients, and diagnostic approaches for interstitial lung disease in immunodeficiency disorders. These works frequently appear in high-impact journals including Science Immunology, Journal of Clinical Immunology, and The Lancet. Chair, NIH Study Section on Investigations on Primary Immunodeficiency Diseases Past President, Clinical Immunology Society Active participant in USIDNET and Primary Immune Deficiency Treatment Consortium Dr. Routes' clinical work focuses on diagnosing and managing complex immunodeficiency cases, with particular expertise in patients with granulomatous-lymphocytic interstitial lung disease (GLILD). His research bridges basic science with clinical practice, contributing significantly to both the understanding of immunological mechanisms and the development of improved diagnostic and therapeutic approaches for patients with primary immunodeficiencies.

• Radiogenomics
• Radiation Oncology
• Normal Tissue Toxicity
• +5 more

Sarah L. Kerns, PhD, is an Associate Professor in the Department of Radiation Oncology at the Medical College of Wisconsin. She holds a BS from the University of Wisconsin-Madison, PhD from Northwestern University, and MPH from Johns Hopkins. Her affiliations include former faculty positions at the University of Rochester and Icahn School of Medicine at Mount Sinai, with active roles in the International Radiogenomics Consortium (Co-Lead) and NCI steering committees. Her research integrates radiogenomics, toxicity prediction modeling, and cancer survivorship, with emphases on: Genetic biomarkers for radiation-induced injury Cisplatin toxicity mechanisms in testicular cancer Inflammatory pathways in cancer-related symptoms Multi-ancestry genomic equity in risk assessment Her publications focus on translating genomic discoveries into clinical tools for personalizing radiotherapy, with recent work on extracellular vesicle proteomics, epigenetic regulators of fibrosis, and polygenic risk scores. Research trends show strong emphasis on prostate cancer toxicity mechanisms, large-scale GWAS meta-analyses, and imaging-genomic correlations. Awards include: NIH Clinical Loan Repayment Award (2017-2021) ASTRO Annual Meeting Award (2010) Predoctoral Fellowship, Chicago Baseball Cancer Charities (2004-2007) She mentors junior faculty and leads NIH-funded projects on biobanking and omega-3 supplementation mechanisms. She directs collaborative initiatives at the Center for Cancer Discovery and oversees genomic components of national consortia like REQUITE.

FARUK DİŞLİView profile

Lecturer

• Physiology
• Immunology
• Stress Response
• +5 more

Dr. Faruk Dişli is a Lecturer at Bingöl University's Faculty of Physiotherapy and Rehabilitation, where he has been affiliated since 2014. His academic journey includes roles as a Research Assistant at Bingöl University and prior clinical experience as a Physical Therapist at rehabilitation centers in Ankara (2013-2014) and Kırıkkale (2008-2013). Educational background: PhD in Physiology, İnönü University Faculty of Medicine Master's in Physiology, İnönü University Faculty of Medicine BSc in Physical Therapy and Rehabilitation, Süleyman Demirel University His research explores interdisciplinary themes in physiology and immunology , with emphasis on: Stress response modulation through virtual reality and physiological biomarkers COVID-19 immunopathology including autoantibody formation and vaccine responses Clinical applications of heart rate variability in urological and autonomic disorders Optimization of diagnostic immunoassays (ELISA) and mitigation of interference factors Dr. Dişli maintains an active publication profile with recent works (2021-2025) demonstrating: Strong focus on SARS-CoV-2 immunology and diagnostics (6 publications) Integration of physiological monitoring with digital health technologies Collaborations across dentistry, biochemistry, and public health domains Current funded projects include: National study on COVID-19-induced autoimmunity (2022-2024) Peri-implant stress marker analysis in periodontal disease (ongoing) He maintains professional membership in the Turkish Physiological Sciences Society (TFBD) and communicates fluently in English.

Donald W. CockcroftView profile

Professor

• Asthma
• Bronchoprovocation
• Allergen Challenge
• +4 more

Donald W. Cockcroft is a distinguished Professor in the Department of Medicine at the University of Saskatchewan, specializing in Respirology, Critical Care and Sleep Medicine. With continuous faculty service since 1977, he has progressed from Assistant Professor (1977-1980) to Associate Professor (1980-1984) and Professor (1984-present), serving as former Head of the Division of Respirology and Critical Care and Sleep Medicine. His educational foundation includes: 1967: BSc in Chemistry, University of British Columbia 1970: MD, University of British Columbia 1975: FRCPC in Internal Medicine, Royal College of Physicians and Surgeons of Canada complemented by specialized training at Montreal's Royal Victoria Hospital (Allergy, 1973-74) and Vancouver's St. Paul's Hospital (Respiratory, 1974-75), followed by asthma research with Freddy Hargreave at McMaster University (1975-77). Dr. Cockcroft's research program pioneers clinical asthma investigations through three interconnected domains: bronchoprovocation methodology (methacholine/nonallergic stimuli), allergen challenge model development, and novel therapeutic evaluation. His work establishes global standards for airway hyperresponsiveness testing while advancing understanding of asthma pathophysiology. Recent publications (2015-2016) demonstrate sustained output across high-impact journals including American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology , with thematic focus on diagnostic refinement, inflammatory mechanisms, and therapeutic innovation. His scientific recognition includes: Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) Fellow of the American Academy of Asthma, Allergy and Immunology Fellow of the American College of Allergy, Asthma and Immunology Fellow of the American College of Chest Physicians Past-President of the Canadian Thoracic Society As an educator, Dr. Cockcroft supervises graduate students (including MSc candidate D. Amakye) and teaches core medical courses while maintaining active clinical practice. His research group operates within Saskatchewan's unique healthcare environment, leveraging population-based studies like the Saskatchewan Rural Health Study to investigate allergy-asthma relationships in rural communities. Though no formal lab name is specified, his team functions as a cohesive clinical research unit focused on translational respiratory medicine.

• Medical Education
• Geriatrics
• Osteoporosis
• +4 more

Neha Mittal serves as Full Professor in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, concurrently functioning as Assistant Dean for Phase 3 Curriculum and Primary Care Physician at Flatonia Community Clinic. Her multifaceted role bridges clinical practice, academic leadership, and medical education innovation across Texas Tech's statewide network. Educational background includes: MD from Sawai Mansingh Medical College, Rajasthan University (1999) Internal Medicine Residency at UPMC McKeesport (2003) Her research spans medical education reform, geriatric osteoporosis management, women's health initiatives, and gastrointestinal disorders. Current work focuses on clerkship curriculum development, osteoporosis screening in high-risk populations, and diagnostic challenges in complex internal medicine cases. She actively investigates healthcare disparities affecting Hispanic communities and innovative approaches to physician promotion equity. Publications reveal strong trends in translational internal medicine research, with recent emphasis on osteoporosis therapeutics, geriatric oncology, and medical education technology. Her work frequently addresses diagnostic dilemmas through case-based analysis while contributing to national initiatives like the Promotion Support for Women in Medicine (PSWIM) program. Award highlights include: Back-to-back Outstanding Clerkship Educator awards (2023-2024) Alpha Omega Alpha Honor Society induction (2022) TTUHSC India Faculty Association recognition (2023) 99 Club teaching excellence award (2022) Grant leadership demonstrates sustained research impact, including principal investigator roles for osteoporosis studies in Hispanic women and elderly men, plus co-investigator positions on Novo Nordisk-funded weight loss response research and Laura W. Bush Institute women's health projects. She serves as Dissertation Committee Member for graduate students and directs statewide preceptorship programs. Current initiatives include developing clinical documentation software to enhance medical student reasoning and equity in clerkship evaluations. Clinical leadership extends to the Multidisciplinary Osteoporosis Clinic and Department of Physical Medicine and Rehabilitation, where she integrates continuing education with direct patient care for complex geriatric cases.